Zimmer Biomet Holdings, Inc.
ZBH
$93.14
$0.550.59%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.24B | 2.00B | 2.08B | 1.91B | 2.02B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.24B | 2.00B | 2.08B | 1.91B | 2.02B |
| Cost of Revenue | 795.50M | 559.30M | 590.70M | 549.80M | 575.20M |
| Gross Profit | 1.45B | 1.44B | 1.49B | 1.36B | 1.45B |
| SG&A Expenses | 838.50M | 809.40M | 807.20M | 756.90M | 703.00M |
| Depreciation & Amortization | 177.70M | 176.50M | 160.60M | 151.00M | 157.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.93B | 1.66B | 1.67B | 1.57B | 1.54B |
| Operating Income | 313.40M | 340.30M | 405.50M | 340.80M | 478.90M |
| Income Before Tax | 97.90M | 279.20M | 224.60M | 229.10M | 289.10M |
| Income Tax Expenses | -39.90M | 48.00M | 71.20M | 46.50M | 48.90M |
| Earnings from Continuing Operations | 137.80M | 231.20M | 153.40M | 182.60M | 240.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.50M | -300.00K | -600.00K | -600.00K | -700.00K |
| Net Income | 139.30M | 230.90M | 152.80M | 182.00M | 239.50M |
| EBIT | 313.40M | 340.30M | 405.50M | 340.80M | 478.90M |
| EBITDA | 597.40M | 623.90M | 677.30M | 595.20M | 742.50M |
| EPS Basic | 0.71 | 1.17 | 0.77 | 0.92 | 1.20 |
| Normalized Basic EPS | 0.80 | 0.85 | 1.03 | 0.87 | 1.25 |
| EPS Diluted | 0.71 | 1.16 | 0.77 | 0.91 | 1.19 |
| Normalized Diluted EPS | 0.80 | 0.85 | 1.03 | 0.87 | 1.25 |
| Average Basic Shares Outstanding | 197.20M | 198.10M | 197.90M | 198.90M | 199.10M |
| Average Diluted Shares Outstanding | 198.10M | 198.80M | 198.30M | 199.70M | 199.90M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | 34.10% | 20.57% | 31.09% | 26.26% | 20.04% |